The Valley Desk

NCT04458857 · Interventional trial

A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age

Overall registry status Completed

Phase 3

Conditions Migraine

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov